Download PDF
Thromb Haemost 1999; 82(06): 1593-1599
DOI: 10.1055/s-0037-1614884
Rapid Communication
Schattauer GmbH

Changes in the Levels of Soluble Adhesion Molecules and Coagulation Factors in Patients with Deep Vein Thrombosis

A. Smith
1   From the Dept. of Surgery, UMDS, St Thomas’ Hospital, London, UK
,
J. W. Quarmby
1   From the Dept. of Surgery, UMDS, St Thomas’ Hospital, London, UK
,
M. Collins
1   From the Dept. of Surgery, UMDS, St Thomas’ Hospital, London, UK
,
S. M. Lockhart
1   From the Dept. of Surgery, UMDS, St Thomas’ Hospital, London, UK
,
K. G. Burnand
1   From the Dept. of Surgery, UMDS, St Thomas’ Hospital, London, UK
› Author AffiliationsWe are grateful to the British Heart Foundation for funding this study.
Further Information

Publication History

Received 19 January 1999

Accepted after revision 30 June 1999

Publication Date:
10 December 2017 (online)

    Permissions and Reprints

Summary

Current biochemical markers of thrombosis, such as d-dimer, are of little value in demonstrating the presence of thrombus postoperatively, as their levels are elevated by surgery. Thrombosis involves adhesive interactions between the endothelium, platelets and leukocytes. The aim of the study was to determine which of a panel of haemostatic and adhesion factors are altered by the presence of thrombus, but not by surgery. These factors were measured in 20 patients with established spontaneous DVTs, 13 patients having hip replacement surgery and 28 control patients. Circulating levels of P-selectin, VCAM-1 and tissue factor were found to be increased when thrombus was present (p <0.018, p <0.0001, p <0.0028 respectively), but were not altered by surgery. The significance of these circulating factors in venous thrombosis remains to be established, but it is conceivable that they are the product of increased leukocyte trafficking and activity. Assay of VCAM-1, in particular, may be of use in the early detection of venous thrombi in postoperative patients.

Key Words

Deep vein thrombosis
 

  • References

  • 1 Yamada N, Wada H, Nakase T, Minamikawa K, Nagaya S, Nakamura M, Hiraoka N, Fuzioka H, Hayashi T. Haemostatic abnormalities in patients with pulmonary embolism compared with deep vein thrombosis. Blood Coag and Fibrinol 1995; 6: 627-33.
    PubMedGoogle Scholar
  • 2 Mossner R, Fassbender MR, Kuhnen J, Schwartz A, Hennerici M. Vascular cell adhesion molecule – a new approach to detect endothelial cell activation in MS and encephalitis. Act Neurol Scand 1996; 93: 118-22.
    CrossrefPubMedGoogle Scholar
  • 3 Zaman AG, Edelsten C, Stanford MR, Graham EM, Ellis BA, Direskeneli H, D’Cruz DP, Hughes RV, Dumonde DC, Wallace GR. Soluble ICAM-1 as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol 1994; 95: 60-5.
    PubMedGoogle Scholar
  • 4 Hackman A, Abe Y, Insull W, Pownall H, Smith L, Dunn K, Gotto A, Ballantyne C. Levels of soluble adhesion molecules in patients with dyslipidemia. Circulation 1996; 93: 1334-8.
    CrossrefPubMedGoogle Scholar
  • 5 Blann A, McCollum CN. Circulating ICAM-1 in peripheral arterial disease as a predictor of adverse events. Lancet 1998; 351: 1135.
    CrossrefPubMedGoogle Scholar
  • 6 Sugama Y, Tiruppathi C, Janakidevi K, Andersen TT, Fenton JW, Malik AB. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: A mechanism for stabilising neutrophil adhesion. J Cell Biol 1992; 119: 935-44.
    CrossrefPubMedGoogle Scholar
  • 7 Cid MC, Kleinman HK, Grant DS. Estradiol enhances leukocyte binding to tumour necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, ICAM-1 and VCAM-1. J Clin Invest 1994; 93: 17-25.
    CrossrefPubMedGoogle Scholar
  • 8 Fries JWU, Williams AJ, Atkins RC. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Path 1993; 143: 725-37.
    PubMedGoogle Scholar
  • 9 Downing LJ, Wakefield TW, Strieter RM, Prince MR, Londy FJ, Fowlkes JB, Hulin DVM, Kadell AM, Wilke CA, Brown SL, Wrobleski SK, Burdick MD, Anderson DC, Greenfield LJ. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 1997; 25: 816-28.
    CrossrefPubMedGoogle Scholar
  • 10 Arcelus JI, Caprini JA, Hoffman KN, Size GP, Fareed J, Hoppensteadt D. Laboratory assays and duplex scanning outcomes after symptomatic deep vein thrombosis: Preliminary results. J Vasc Surg 1996; 23: 616-21.
    CrossrefPubMedGoogle Scholar
  • 11 Giercksky KE, Bjorklid E, Prydz H, Renck H. Circulating tissue thromboplastin during hip surgery. Eur Surg Res 1979; 11: 296-300.
    CrossrefPubMedGoogle Scholar
  • 12 Fareed J, Callas DD, Hoppensteadt D, Bermes EW. Tissue factor antigen levels in various biological fluids. Blood Coagulation and Fibrinolysis 1995; 6: S32-6.
    PubMedGoogle Scholar
  • 13 Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 67-79.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Bevilaqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA. Recombinant TNF induces procoagulant activity in cultured human vascular endothelium: Characterisation and comparison with the actions of IL-1. Proc Natl Acad Sci USA 1986; 83: 3460-4.
    CrossrefPubMedGoogle Scholar
  • 15 Satta N, Toti F, Feugeas O, Bohbot A, Prigent J, Eschwege V, Hedman H, Freyssinet JM. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation with LPS. J Immunol 1994; 153: 3245-55.
    PubMedGoogle Scholar
  • 16 Wilcox JN, Smith KM, Scwartz SM, Gordon D. Localisation of tissue factor in normal vessel wall and in atherosclerotic plaque. Proc Natl Acad Sci 1989; 86: 2839-43.
    CrossrefPubMedGoogle Scholar
  • 17 Davi G, Romano M, Mezzetti A, Procopio A, Iacobelli S, Antidormi T, Bucciarelli T, Alessandrini P, Cuccurullo F, Bittolo G. Increased levels of soluble P-selectin in hypercholesterolaemic patients. Circulation 1998; 97: 953-7.
    CrossrefPubMedGoogle Scholar
  • 18 Jilma B, Eichler HG, Vondrovec B, Breiteneder H, Kyrle PA, Kitzweger E, Kapiotis S, Speiser W. Effects of DDAVP on circulating P-selectin. Br J Haematol 1996; 93: 432-6.
    CrossrefPubMedGoogle Scholar
  • 19 Gordon JL, Edwards RM, Cashman SJ, Rees AJ, Gearing AJH. Circulating endothelial cell adhesion molecules. Vascular Endothelium. Catravas JD. (ed.) NY: Plenum Press; 1993
    Google Scholar
  • 20 Ley K. Leukocyte adhesion to vascular endothelium. J Recon Microsurg 1992; 8: 495-3.
    PubMedGoogle Scholar
  • 21 Roth GJ. Platelets and blood vessels: the adhesion event. Immunol Today 1992; 13: 100-5.
    CrossrefPubMedGoogle Scholar
  • 22 Tedder TF, Steeber DA, Chen A, Engel P. The selectins: Vascular adhesion molecules. FASEB J 1995; 9: 866-73.
    CrossrefPubMedGoogle Scholar
  • 23 Johnston GI, Bliss GA, Newman PJ, McEver RP. Structure of the human gene encoding GMP140, a member of the selectin family of adhesion receptors for leukocytes. J Biol Chem 1990; 265: 21381-5.
    PubMedGoogle Scholar
  • 24 Palabrica T, Lobb R, Furie BC. Leukocyte accumulation promoting fibrin deposition, is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 359: 848-51.
    CrossrefPubMedGoogle Scholar
  • 25 Furie B, Celi A, Palabrica TM. PADGEM, a leukocyte recepor on activated platelets. Curr Stud Hematol Blood Trans 1991; 58: 32-6.
    PubMedGoogle Scholar
  • 26 Adams DH, Shaw S. Leukocyte endothelial interactions and regulation of leukocyte migration. Lancet 1994; 343: 831-6.
    CrossrefPubMedGoogle Scholar
  • 27 Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301-14.
    CrossrefPubMedGoogle Scholar
  • 28 Northeast ADR, Soo KS, Bobrow LG, Gaffney PJ, Burnand KG. The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus. J Vasc Surg 1995; 22: 573-9.
    CrossrefPubMedGoogle Scholar
  • 29 McGuinness C, Humphries J, Smith A, Collins M, Poston R, Burnand KG. MCP-1 accelerates the organisation of venous thrombi. J Vasc Surg 1999; 30: 894-900.
    CrossrefPubMedGoogle Scholar